Convalescent Plasma News and Research

RSS
SARS-CoV-2 variants containing L452R spike mutation more resistant to antibody-mediated neutralization

SARS-CoV-2 variants containing L452R spike mutation more resistant to antibody-mediated neutralization

Plant-based virus-like particle vaccine induces durable immune response against SARS-CoV-2 variants

Plant-based virus-like particle vaccine induces durable immune response against SARS-CoV-2 variants

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

Study shows COVID-19 organ-specific outcomes depend on anti-spike glycoprotein antibodies

Study shows COVID-19 organ-specific outcomes depend on anti-spike glycoprotein antibodies

Intradermal administration of low-dose mRNA COVID-19 vaccine induces strong immune response, study finds

Intradermal administration of low-dose mRNA COVID-19 vaccine induces strong immune response, study finds

Scientists develop a potent peptide inhibitor of SARS-CoV-2 in vitro

Scientists develop a potent peptide inhibitor of SARS-CoV-2 in vitro

Combination antibody therapies retain potency against SARS-CoV-2 variants, FDA / HHS research

Combination antibody therapies retain potency against SARS-CoV-2 variants, FDA / HHS research

Past SARS-CoV-2 infection enhances mRNA vaccine-induced neutralization of variants of concern

Past SARS-CoV-2 infection enhances mRNA vaccine-induced neutralization of variants of concern

Study sheds light on immune processes involved in long COVID

Study sheds light on immune processes involved in long COVID

Scientists study how our immune system responds to COVID-19 variants

Scientists study how our immune system responds to COVID-19 variants

B.1.427/B.1.429 variant of SARS-CoV-2 evades neutralization via disulfide bond rearrangement

B.1.427/B.1.429 variant of SARS-CoV-2 evades neutralization via disulfide bond rearrangement

New study reports low SARS-CoV-2 breakthrough infections in vaccinated healthcare workers

New study reports low SARS-CoV-2 breakthrough infections in vaccinated healthcare workers

Stool transplant may be worth exploring as treatment option for COVID-19

Stool transplant may be worth exploring as treatment option for COVID-19

Antibody development against SARS-CoV-2 following Moderna vaccine

Antibody development against SARS-CoV-2 following Moderna vaccine

H69/V70 deletion in Alpha variant enables SARS-CoV-2 to overcome chinks in its armor

H69/V70 deletion in Alpha variant enables SARS-CoV-2 to overcome chinks in its armor

Vaccines and drugs must be adapted to combat emerging SARS-CoV-2 variants, says study

Vaccines and drugs must be adapted to combat emerging SARS-CoV-2 variants, says study

Why SARS-CoV-2 delta variant is more infectious

Why SARS-CoV-2 delta variant is more infectious

A study on hospitalized COVID-19 patients who received plasma therapy

A study on hospitalized COVID-19 patients who received plasma therapy

Longitudinal study finds SARS-CoV-2 neutralizing antibodies decline a year after infection

Longitudinal study finds SARS-CoV-2 neutralizing antibodies decline a year after infection

GenScript and Duke-NUS announce notice of allowance for “Surrogate Virus Neutralization Technology”

GenScript and Duke-NUS announce notice of allowance for “Surrogate Virus Neutralization Technology”